drugset / Trial / NCT00694980
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized , double-blind, placebo-controlled study of approximately 70 patients with ulcerative colitis.
Timeline
- Start
- 2008-09
- Primary completion
- 2011-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Etrolizumab | Monoclonal antibody | — | Intravenous |